Company
MedRx Co. Ltd
Headquarters: Higashikagawa, Japan
Employees: 24
CEO: Mr. Yonehiro Matsumura
Market Cap
¥6.33 Billion
JPY as of Jan. 1, 2024
US$44.9 Million
MedRx Co. Ltd Categories
Japan Healthcare Drug Manufacturers—Specialty & GenericJapan Healthcare Japan Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
MedRx Co., Ltd, a pharmaceutical company, develops pharmaceutical drugs based on the transdermal absorption system in Japan. It develops medicines based on Ionic liquid transdermal system. The company's products pipeline include MRX-4TZT, which is in phase II; MRX-5LBT, which is phase III; MRX-10XT, which is in phase I; and MRX-7MLL, which is in pre-clinical stage. It also offers micro needle patches for delivery of vaccines and/or APIs through skin, as well as adhesive skin patches. The company was founded in 2002 and is headquartered in Higashikagawa, Japan.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
MedRx Co. Ltd has the following listings and related stock indices.
Stock: JPX: 4586 wb_incandescent